Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2026 and provided a business update. “Following a successful 2025, we are ...
Some yogurts and peanut butters could be considered ultraprocessed as scientists and MAHA supporters push for a strict ...
Discover how preferred provider organizations (PPOs) work, their benefits over HMOs, and why they might be the right health ...
No. 11 / 2026Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight ...
Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.
A comprehensive overview of biosolids management, including federal regulations under the Clean Water Act, state laws like ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir Biotechnology, Inc. (NASDAQ:VIR) announced that the first patient had been dosed in one ...
CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. These 10 stocks could mint the next wave of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results